Sodium-Glucose Cotransporter 2 Inhibitors and Nephrolithiasis
23.03.2024 | Julie M. Paik, MD, ScD, MPH; Helen Tesfaye, PharmD, MSc; Gary C. Curhan, MD, ScD; Heidi Zakoul, BA; Deborah J. Wexler, MD, MSc; Elisabetta Patorno, MD, DrPH
JAMA Intern Med. 2024; 184(7):852-853. 10.1001/jamainternmed.2024.1741